Global GM1 Gangliosidosis Treatment Supply, Demand and Key Producers, 2024-2030

Page: 83

Published Date: 14 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global GM1 Gangliosidosis Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain.

This report studies the global GM1 Gangliosidosis Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for GM1 Gangliosidosis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of GM1 Gangliosidosis Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global GM1 Gangliosidosis Treatment total market, 2019-2030, (USD Million)
Global GM1 Gangliosidosis Treatment total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: GM1 Gangliosidosis Treatment total market, key domestic companies and share, (USD Million)
Global GM1 Gangliosidosis Treatment revenue by player and market share 2019-2024, (USD Million)
Global GM1 Gangliosidosis Treatment total market by Type, CAGR, 2019-2030, (USD Million)
Global GM1 Gangliosidosis Treatment total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global GM1 Gangliosidosis Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Axovant Gene Therapies Ltd and Passage Bio and Lysogene etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GM1 Gangliosidosis Treatment market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global GM1 Gangliosidosis Treatment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global GM1 Gangliosidosis Treatment Market, Segmentation by Type
LYS-GM101
PBGM01
AXO-AAV-GM1

Global GM1 Gangliosidosis Treatment Market, Segmentation by Application
Type 1 GM1 Gangliosidosis
Type 2 GM1 Gangliosidosis
Type 3 GM1 Gangliosidosis

Companies Profiled:
Axovant Gene Therapies Ltd
Passage Bio and Lysogene

Key Questions Answered
1. How big is the global GM1 Gangliosidosis Treatment market?
2. What is the demand of the global GM1 Gangliosidosis Treatment market?
3. What is the year over year growth of the global GM1 Gangliosidosis Treatment market?
4. What is the total value of the global GM1 Gangliosidosis Treatment market?
5. Who are the major players in the global GM1 Gangliosidosis Treatment market?

Table of Contents

1 Supply Summary
    1.1 GM1 Gangliosidosis Treatment Introduction
    1.2 World GM1 Gangliosidosis Treatment Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World GM1 Gangliosidosis Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World GM1 Gangliosidosis Treatment Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States GM1 Gangliosidosis Treatment Market Size (2019-2030)
        1.3.3 China GM1 Gangliosidosis Treatment Market Size (2019-2030)
        1.3.4 Europe GM1 Gangliosidosis Treatment Market Size (2019-2030)
        1.3.5 Japan GM1 Gangliosidosis Treatment Market Size (2019-2030)
        1.3.6 South Korea GM1 Gangliosidosis Treatment Market Size (2019-2030)
        1.3.7 ASEAN GM1 Gangliosidosis Treatment Market Size (2019-2030)
        1.3.8 India GM1 Gangliosidosis Treatment Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 GM1 Gangliosidosis Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 GM1 Gangliosidosis Treatment Major Market Trends

2 Demand Summary
    2.1 World GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.2 World GM1 Gangliosidosis Treatment Consumption Value by Region
        2.2.1 World GM1 Gangliosidosis Treatment Consumption Value by Region (2019-2024)
        2.2.2 World GM1 Gangliosidosis Treatment Consumption Value Forecast by Region (2025-2030)
    2.3 United States GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.4 China GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.5 Europe GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.6 Japan GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.7 South Korea GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.8 ASEAN GM1 Gangliosidosis Treatment Consumption Value (2019-2030)
    2.9 India GM1 Gangliosidosis Treatment Consumption Value (2019-2030)

3 World GM1 Gangliosidosis Treatment Companies Competitive Analysis
    3.1 World GM1 Gangliosidosis Treatment Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global GM1 Gangliosidosis Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for GM1 Gangliosidosis Treatment in 2023
        3.2.3 Global Concentration Ratios (CR8) for GM1 Gangliosidosis Treatment in 2023
    3.3 GM1 Gangliosidosis Treatment Company Evaluation Quadrant
    3.4 GM1 Gangliosidosis Treatment Market: Overall Company Footprint Analysis
        3.4.1 GM1 Gangliosidosis Treatment Market: Region Footprint
        3.4.2 GM1 Gangliosidosis Treatment Market: Company Product Type Footprint
        3.4.3 GM1 Gangliosidosis Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: GM1 Gangliosidosis Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: GM1 Gangliosidosis Treatment Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: GM1 Gangliosidosis Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: GM1 Gangliosidosis Treatment Consumption Value Comparison
        4.2.1 United States VS China: GM1 Gangliosidosis Treatment Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: GM1 Gangliosidosis Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based GM1 Gangliosidosis Treatment Companies and Market Share, 2019-2024
        4.3.1 United States Based GM1 Gangliosidosis Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies GM1 Gangliosidosis Treatment Revenue, (2019-2024)
    4.4 China Based Companies GM1 Gangliosidosis Treatment Revenue and Market Share, 2019-2024
        4.4.1 China Based GM1 Gangliosidosis Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies GM1 Gangliosidosis Treatment Revenue, (2019-2024)
    4.5 Rest of World Based GM1 Gangliosidosis Treatment Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based GM1 Gangliosidosis Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies GM1 Gangliosidosis Treatment Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World GM1 Gangliosidosis Treatment Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 LYS-GM101
        5.2.2 PBGM01
        5.2.3 AXO-AAV-GM1
    5.3 Market Segment by Type
        5.3.1 World GM1 Gangliosidosis Treatment Market Size by Type (2019-2024)
        5.3.2 World GM1 Gangliosidosis Treatment Market Size by Type (2025-2030)
        5.3.3 World GM1 Gangliosidosis Treatment Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World GM1 Gangliosidosis Treatment Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Type 1 GM1 Gangliosidosis
        6.2.2 Type 2 GM1 Gangliosidosis
        6.2.3 Type 3 GM1 Gangliosidosis
    6.3 Market Segment by Application
        6.3.1 World GM1 Gangliosidosis Treatment Market Size by Application (2019-2024)
        6.3.2 World GM1 Gangliosidosis Treatment Market Size by Application (2025-2030)
        6.3.3 World GM1 Gangliosidosis Treatment Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Axovant Gene Therapies Ltd
        7.1.1 Axovant Gene Therapies Ltd Details
        7.1.2 Axovant Gene Therapies Ltd Major Business
        7.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product and Services
        7.1.4 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Axovant Gene Therapies Ltd Recent Developments/Updates
        7.1.6 Axovant Gene Therapies Ltd Competitive Strengths & Weaknesses
    7.2 Passage Bio and Lysogene
        7.2.1 Passage Bio and Lysogene Details
        7.2.2 Passage Bio and Lysogene Major Business
        7.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product and Services
        7.2.4 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Passage Bio and Lysogene Recent Developments/Updates
        7.2.6 Passage Bio and Lysogene Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 GM1 Gangliosidosis Treatment Industry Chain
    8.2 GM1 Gangliosidosis Treatment Upstream Analysis
    8.3 GM1 Gangliosidosis Treatment Midstream Analysis
    8.4 GM1 Gangliosidosis Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World GM1 Gangliosidosis Treatment Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World GM1 Gangliosidosis Treatment Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World GM1 Gangliosidosis Treatment Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World GM1 Gangliosidosis Treatment Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World GM1 Gangliosidosis Treatment Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World GM1 Gangliosidosis Treatment Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World GM1 Gangliosidosis Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World GM1 Gangliosidosis Treatment Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World GM1 Gangliosidosis Treatment Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key GM1 Gangliosidosis Treatment Players in 2023
    Table 12. World GM1 Gangliosidosis Treatment Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global GM1 Gangliosidosis Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key GM1 Gangliosidosis Treatment Player
    Table 15. GM1 Gangliosidosis Treatment Market: Company Product Type Footprint
    Table 16. GM1 Gangliosidosis Treatment Market: Company Product Application Footprint
    Table 17. GM1 Gangliosidosis Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China GM1 Gangliosidosis Treatment Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China GM1 Gangliosidosis Treatment Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based GM1 Gangliosidosis Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies GM1 Gangliosidosis Treatment Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies GM1 Gangliosidosis Treatment Revenue Market Share (2019-2024)
    Table 23. China Based GM1 Gangliosidosis Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies GM1 Gangliosidosis Treatment Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies GM1 Gangliosidosis Treatment Revenue Market Share (2019-2024)
    Table 26. Rest of World Based GM1 Gangliosidosis Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies GM1 Gangliosidosis Treatment Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies GM1 Gangliosidosis Treatment Revenue Market Share (2019-2024)
    Table 29. World GM1 Gangliosidosis Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World GM1 Gangliosidosis Treatment Market Size by Type (2019-2024) & (USD Million)
    Table 31. World GM1 Gangliosidosis Treatment Market Size by Type (2025-2030) & (USD Million)
    Table 32. World GM1 Gangliosidosis Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World GM1 Gangliosidosis Treatment Market Size by Application (2019-2024) & (USD Million)
    Table 34. World GM1 Gangliosidosis Treatment Market Size by Application (2025-2030) & (USD Million)
    Table 35. Axovant Gene Therapies Ltd Basic Information, Area Served and Competitors
    Table 36. Axovant Gene Therapies Ltd Major Business
    Table 37. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product and Services
    Table 38. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Axovant Gene Therapies Ltd Recent Developments/Updates
    Table 40. Passage Bio and Lysogene Basic Information, Area Served and Competitors
    Table 41. Passage Bio and Lysogene Major Business
    Table 42. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product and Services
    Table 43. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 44. Global Key Players of GM1 Gangliosidosis Treatment Upstream (Raw Materials)
    Table 45. GM1 Gangliosidosis Treatment Typical Customers
List of Figure
    Figure 1. GM1 Gangliosidosis Treatment Picture
    Figure 2. World GM1 Gangliosidosis Treatment Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World GM1 Gangliosidosis Treatment Total Market Size (2019-2030) & (USD Million)
    Figure 4. World GM1 Gangliosidosis Treatment Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World GM1 Gangliosidosis Treatment Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company GM1 Gangliosidosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 13. GM1 Gangliosidosis Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 16. World GM1 Gangliosidosis Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 18. China GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. India GM1 Gangliosidosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of GM1 Gangliosidosis Treatment by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for GM1 Gangliosidosis Treatment Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for GM1 Gangliosidosis Treatment Markets in 2023
    Figure 27. United States VS China: GM1 Gangliosidosis Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: GM1 Gangliosidosis Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World GM1 Gangliosidosis Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World GM1 Gangliosidosis Treatment Market Size Market Share by Type in 2023
    Figure 31. LYS-GM101
    Figure 32. PBGM01
    Figure 33. AXO-AAV-GM1
    Figure 34. World GM1 Gangliosidosis Treatment Market Size Market Share by Type (2019-2030)
    Figure 35. World GM1 Gangliosidosis Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2023
    Figure 37. Type 1 GM1 Gangliosidosis
    Figure 38. Type 2 GM1 Gangliosidosis
    Figure 39. Type 3 GM1 Gangliosidosis
    Figure 40. GM1 Gangliosidosis Treatment Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Axovant Gene Therapies Ltd
Passage Bio and Lysogene

Related Reports

Global GM1 Gangliosidosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global GM1 Gangliosidosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 08 Jan 2023

date Pharma & Healthcare

GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain.

Global GM1 Gangliosidosis Treatment Supply, Demand and Key Producers, 2023-2029

Global GM1 Gangliosidosis Treatment Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Pharma & Healthcare

The global GM1 Gangliosidosis Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global GM1 Gangliosidosis Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global GM1 Gangliosidosis Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global GM1 Gangliosidosis Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

GM1 Gangliosidosis Treatment

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>